$NLNK Recent News Some of the Nasdaq’s leadi
Post# of 102233
Some of the Nasdaq’s leading lights have begun to dim 2:03 p.m. Jan. 15, 2015 - The Trading Deck
Leading growth stocks continue to shine 3:08 p.m. Jan. 13, 2015 - The Trading Deck
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Longer-term signposts point stocks higher 2:55 p.m. Jan. 5, 2015 - The Trading Deck
S&P 500 ventures under the 50-day average 11:30 a.m. Jan. 5, 2015 - Michael Ashbaugh
If seasonal script plays out, January stocks will be bullish 2:53 p.m. Dec. 29, 2014 - The Trading Deck
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
6 stocks to watch 3:29 p.m. Dec. 10, 2014 - The Trading Deck
Bull trend absorbs latest market whipsaw 11:23 a.m. Dec. 10, 2014 - Michael Ashbaugh
Merck obtains right to experimental Ebola vaccine 11:23 a.m. Nov. 24, 2014 - Peter Loftus
Merck, NewLink to collaborate on Ebola vaccine 7:56 a.m. Nov. 24, 2014 - Ciara Linnane
4 stocks to watch 1:44 p.m. Nov. 19, 2014 - The Trading Deck
Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
NewLink Genetics shares rally 3.4% in premarket trade 7:02 a.m. Oct. 24, 2014 - Tomi Kilgore
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Ebola-nation travelers to U.S. to be watched 21 days 2:04 p.m. Oct. 22, 2014 - Russ Britt
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Small victories recorded in fight against Ebola 11:22 a.m. Oct. 20, 2014 - Russ Britt
Sarepta says its Ebola drug has no ill effects 4:28 p.m. Oct. 16, 2014 - Russ Britt
U.S. to pull troops from Ebola zone 3:38 a.m. Feb. 11, 2015 - Seeking Alpha
Interesting NLNK Put And Call Options For March 20th 10:54 a.m. Feb. 4, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX IRWD LGND NLNK 12:15 p.m. Jan. 26, 2015 - InvestorPlace.com
TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog 12:00 p.m. Jan. 26, 2015 - Zacks.com
NIH to Start Ebola Vaccine Study With Glaxo, Merck 9:05 a.m. Jan. 23, 2015 - The Wall Street Journal Interactive Edition
Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog 5:50 p.m. Jan. 22, 2015 - Zacks.com
Affymetrix (AFFX) Expands Genotyping Arrays Product Line - Analyst Blog 1:10 p.m. Jan. 12, 2015 - Zacks.com
Biotech Weekly: Lessons Learned From Investing In Ebola Stocks 8:38 a.m. Jan. 12, 2015 - Seeking Alpha
InsiderInsights.com Daily Round Up 1/8/15: CPRX, HCOM, RPXC, ARIS 3:07 a.m. Jan. 10, 2015 - Seeking Alpha
Biogen Reveals Positive Data from Acute Optic Neuritis Study - Analyst Blog 5:35 p.m. Jan. 9, 2015 - Zacks.com
Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
Ebola Vaccine Tests Resume 10:39 a.m. Jan. 5, 2015 - The Wall Street Journal Interactive Edition
Biggest Movers in Healthcare Stocks Now – NLNK ACHN MNKD VRTX 1:30 p.m. Jan. 2, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN MNKD VRTX NLNK 9:45 a.m. Jan. 2, 2015 - InvestorPlace.com
Scotland confirms Ebola case 1:53 a.m. Dec. 30, 2014 - Seeking Alpha
NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog 12:00 p.m. Dec. 29, 2014 - Zacks.com
Viral Investing: Ebola Drug Makers' Varied Strategies 3:09 p.m. Dec. 26, 2014 - Investors Business Daily
BARDA awards Ebola vaccine contract to NewLink Genetics 8:44 a.m. Dec. 22, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACHN EXAS CBPO ABMD 7:30 a.m. Dec. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NLNK MACK ELGX HZNP 3:00 p.m. Dec. 19, 2014 - InvestorPlace.com
Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics 9:00 a.m. Jan. 20, 2015 - PR Newswire - PRF
Critical Alerts For Ford, BlackBerry, Aegerion Pharmaceuticals, Yahoo! and NewLink Genetics Released By InvestorsObserver 9:31 a.m. Jan. 15, 2015 - PR Newswire - PRF
NewLink Genetics to Present at the 33rd Annual J.P. Morgan Healthcare Conference 5:01 p.m. Jan. 7, 2015 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Ebola Stocks on the Rise as Death Toll Hits 5,000 12:28 p.m. Dec. 1, 2014 - ACCESSWIRE
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine 7:31 a.m. Nov. 24, 2014 - GlobeNewswire
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine 7:31 a.m. Nov. 24, 2014 - BusinessWire - BZX
NewLink Genetics to Participate in the Upcoming Stifel, Jeffries, and Piper Jaffray Healthcare Conferences 7:01 a.m. Nov. 17, 2014 - GlobeNewswire
NewLink Genetics Appoints Thomas P. Monath, M.D. to the Position of Chief Scientific and Chief Operations Officer of BioProtection Systems Corporation, Its Infectious Disease Division 10:07 a.m. Nov. 14, 2014 - GlobeNewswire
Critical Alerts For Noodles & Company, NewLink Genetics, Under Armour, JP Morgan Chase and Baidu Released By InvestorsObserver 9:31 a.m. Nov. 7, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 6, 2014 - GlobeNewswire
Heat Biologics Takes a New Approach to Immunotherapy 2:01 p.m. Nov. 3, 2014 - ACCESSWIRE
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 7:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 8:22 a.m. Oct. 28, 2014 - ACCESSWIRE
NewLink Genetics to Host Its Third Quarter 2014 Earnings Results Conference Call on November 6, 2014 7:01 a.m. Oct. 27, 2014 - GlobeNewswire
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 12:47 p.m. Oct. 21, 2014 - ACCESSWIRE
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:22 a.m. Oct. 20, 2014 - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 6:01 a.m. Oct. 20, 2014 - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 6:01 a.m. Oct. 20, 2014 - Marketwired